These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 21721074)

  • 1. Sustained, high transgene expression in liver with plasmid vectors using optimized promoter-enhancer combinations.
    Magnusson T; Haase R; Schleef M; Wagner E; Ogris M
    J Gene Med; 2011 Jul; 13(7-8):382-91. PubMed ID: 21721074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High and sustained transgene expression in vivo from plasmid vectors containing a hybrid ubiquitin promoter.
    Yew NS; Przybylska M; Ziegler RJ; Liu D; Cheng SH
    Mol Ther; 2001 Jul; 4(1):75-82. PubMed ID: 11472109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained liver-specific transgene expression from the albumin promoter in mice following hydrodynamic plasmid DNA delivery.
    Wooddell CI; Reppen T; Wolff JA; Herweijer H
    J Gene Med; 2008 May; 10(5):551-63. PubMed ID: 18330848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1alpha promoter.
    Gill DR; Smyth SE; Goddard CA; Pringle IA; Higgins CF; Colledge WH; Hyde SC
    Gene Ther; 2001 Oct; 8(20):1539-46. PubMed ID: 11704814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activator protein 1-mediated transcriptional regulation strategy sustains long-term expression of a xenogeneic gene product in vivo: an implication for gene therapy targeting congenital protein deficiencies.
    Sasaki S; Smith JM; Takase K; Okuda K; Ishii N; Takeshita F
    Int J Mol Med; 2006 Aug; 18(2):289-97. PubMed ID: 16820937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CpG-free plasmid expression cassettes for cystic fibrosis gene therapy.
    Pringle IA; Hyde SC; Connolly MM; Lawton AE; Xu B; Nunez-Alonso G; Davies LA; Sumner-Jones SG; Gill DR
    Biomaterials; 2012 Oct; 33(28):6833-42. PubMed ID: 22727465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CMV enhancer/human PDGF-beta promoter for neuron-specific transgene expression.
    Liu BH; Wang X; Ma YX; Wang S
    Gene Ther; 2004 Jan; 11(1):52-60. PubMed ID: 14681697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgene loss and changes in the promoter methylation status as determinants for expression duration in nonviral gene transfer for factor IX.
    Schüttrumpf J; Milanov P; Abriss D; Roth S; Tonn T; Seifried E
    Hum Gene Ther; 2011 Jan; 22(1):101-6. PubMed ID: 20677911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time course of gene expression after plasmid DNA gene transfer to the liver.
    Herweijer H; Zhang G; Subbotin VM; Budker V; Williams P; Wolff JA
    J Gene Med; 2001; 3(3):280-91. PubMed ID: 11437333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low generation PAMAM dendrimer and CpG free plasmids allow targeted and extended transgene expression in tumors after systemic delivery.
    Navarro G; Maiwald G; Haase R; Rogach AL; Wagner E; de Ilarduya CT; Ogris M
    J Control Release; 2010 Aug; 146(1):99-105. PubMed ID: 20438778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte-specific gene expression from integrated lentiviral vectors.
    Nash KL; Jamil B; Maguire AJ; Alexander GJ; Lever AM
    J Gene Med; 2004 Sep; 6(9):974-83. PubMed ID: 15352070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscle creatine kinase/SV40 hybrid promoter for muscle-targeted long-term transgene expression.
    Takeshita F; Takase K; Tozuka M; Saha S; Okuda K; Ishii N; Sasaki S
    Int J Mol Med; 2007 Feb; 19(2):309-15. PubMed ID: 17203206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of plasmid vectors for high-level expression in lung epithelial cells.
    Yew NS; Wysokenski DM; Wang KX; Ziegler RJ; Marshall J; McNeilly D; Cherry M; Osburn W; Cheng SH
    Hum Gene Ther; 1997 Mar; 8(5):575-84. PubMed ID: 9095409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Tet-on system to avoid transgene down-regulation in ex vivo gene transfer to the CNS.
    Johansen J; Rosenblad C; Andsberg K; Møller A; Lundberg C; Björlund A; Johansen TE
    Gene Ther; 2002 Oct; 9(19):1291-301. PubMed ID: 12224012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained expression after nonviral ocular gene transfer using mammalian promoters.
    Kachi S; Esumi N; Zack DJ; Campochiaro PA
    Gene Ther; 2006 May; 13(9):798-804. PubMed ID: 16467860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of promoter strength for hepatic gene expression in vivo following adenovirus-mediated gene transfer.
    Guo ZS; Wang LH; Eisensmith RC; Woo SL
    Gene Ther; 1996 Sep; 3(9):802-10. PubMed ID: 8875229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lentiviral vectors for enhanced gene expression in human hematopoietic cells.
    Ramezani A; Hawley TS; Hawley RG
    Mol Ther; 2000 Nov; 2(5):458-69. PubMed ID: 11082319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved neuronal transgene expression from an AAV-2 vector with a hybrid CMV enhancer/PDGF-beta promoter.
    Wang CY; Guo HY; Lim TM; Ng YK; Neo HP; Hwang PY; Yee WC; Wang S
    J Gene Med; 2005 Jul; 7(7):945-55. PubMed ID: 15756650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrodynamic plasmid DNA gene therapy model in liver transplantation.
    Tsoulfas G; Takahashi Y; Liu D; Yagnik G; Wu T; Murase N; Geller DA
    J Surg Res; 2006 Oct; 135(2):242-9. PubMed ID: 16926028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the content of unmethylated CpG dinucleotides in plasmid DNA on the sustainability of transgene expression.
    Mitsui M; Nishikawa M; Zang L; Ando M; Hattori K; Takahashi Y; Watanabe Y; Takakura Y
    J Gene Med; 2009 May; 11(5):435-43. PubMed ID: 19291673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.